{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699995981138432.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1056/nejmoa011161"}},{"identifier":{"@type":"URI","@value":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa011161"}},{"identifier":{"@type":"NAID","@value":"30022555104"}}],"dc:title":[{"@value":"Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699995981138307","@type":"Researcher","foaf:name":[{"@value":"Barry M. Brenner"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995981138306","@type":"Researcher","foaf:name":[{"@value":"Mark E. Cooper"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995981138305","@type":"Researcher","foaf:name":[{"@value":"Dick de Zeeuw"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995981138433","@type":"Researcher","foaf:name":[{"@value":"William F. Keane"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995981138309","@type":"Researcher","foaf:name":[{"@value":"William E. Mitch"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995981138308","@type":"Researcher","foaf:name":[{"@value":"Hans-Henrik Parving"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995981138311","@type":"Researcher","foaf:name":[{"@value":"Giuseppe Remuzzi"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995981138304","@type":"Researcher","foaf:name":[{"@value":"Steven M. Snapinn"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995981138432","@type":"Researcher","foaf:name":[{"@value":"Zhonxin Zhang"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995981138310","@type":"Researcher","foaf:name":[{"@value":"Shahnaz Shahinfar"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00284793"},{"@type":"EISSN","@value":"15334406"},{"@type":"PISSN","@value":"http://id.crossref.org/issn/00284793"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/00284793"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/00257850"},{"@type":"NCID","@value":"AA00755156"}],"prism:publicationName":[{"@value":"New England Journal of Medicine"}],"dc:publisher":[{"@value":"Massachusetts Medical Society"}],"prism:publicationDate":"2001-09-20","prism:volume":"345","prism:number":"12","prism:startingPage":"861","prism:endingPage":"869"},"reviewed":"false","url":[{"@id":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa011161"}],"createdAt":"2002-07-27","modifiedAt":"2024-12-09","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050001335835604608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Ablation of the N-type calcium channel ameliorates diabetic nephropathy with improved glycemic control and reduced blood pressure"}]},{"@id":"https://cir.nii.ac.jp/crid/1050282810792963968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The organ-protective effect of N-type Ca(2+) channel blockade."}]},{"@id":"https://cir.nii.ac.jp/crid/1050282812375080192","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"腎臓保護の新しい方略 : 降圧療法の次にするべきこと"},{"@language":"ja-Kana","@value":"ジュショウ キネン コウザ サンシカイ ショウレイショウ ジンゾウ ホゴ ノ アタラシイ ホウリャク コウアツ リョウホウ ノ ツギ ニ スルベキ コト"}]},{"@id":"https://cir.nii.ac.jp/crid/1050282812375151872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"生体内CCDカメラを用いた腎輸入・輸出細動脈の反応性の層差に関する研究"},{"@language":"ja-Kana","@value":"ガクイ ロンブン セイタイナイ CCD カメラ オ モチイタ ジンユニュウ ユシュツサイドウミャク ノ ハンノウセイ ノ ソウサ ニ カンスル ケンキュウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1050285299951255936","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Randomized trial of an intensified, multifactorial intervention in patients with advanced‐stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT‐Japan)"},{"@value":"Randomized trial of an intensified, multifactorial intervention in patients with advanced-stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan)"}]},{"@id":"https://cir.nii.ac.jp/crid/1050304183895012480","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The effect of aldosterone and aldosterone blockade on the progression of chronic kidney disease : a randomized placebo-controlled clinical trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1050564285904415744","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A crossover comparison of urinary albumin excretion as a new surrogate marker for cardiovascular disease among 4 types of calcium channel blockers"}]},{"@id":"https://cir.nii.ac.jp/crid/1050565163713276672","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"High glucose level and angiotensin II type 1 receptor stimulation synergistically amplify oxidative stress in renal mesangial cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1050867133851167104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effect of Saxagliptin on Endothelial Function in Patients with Type 2 Diabetes : A Prospective Multicenter Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1050867133854779264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Nitrosonifedipine Ameliorates the Progression of Type 2 Diabetic Nephropathy by Exerting Antioxidative Effects"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002216791665280","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I–II essential hypertension: a randomized, double-blind clinical study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232095870720","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of renin–angiotensin system blockades on cardiovascular outcomes in patients with diabetes mellitus: A systematic review and meta-analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232116980224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Telmisartan increases localization of glucose transporter 4 to the plasma membrane and increases glucose uptake via peroxisome proliferator-activated receptor γ in 3T3-L1 adipocytes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232470412160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Long-term observations of radiation-induced creatinine clearance reduction and renal parenchymal volume atrophy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004233406115328","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renoprotective and antioxidant effects of cilnidipine in hypertensive patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004233413039744","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"An angiotensin II receptor blocker–calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004234890435968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Aliskiren enhances protective effects of valsartan against type 2 diabetic nephropathy in mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004234890471936","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Novel mechanism of salt-induced glomerular injury"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004236318400896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Vascular smooth muscle insulin resistance, but not hypertrophic signaling, is independent of angiotensin II-induced IRS-1 phosphorylation by JNK"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004236339663744","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Regulation of Posttranscriptional Modification as a Possible Therapeutic Approach for Retinal Neuroprotection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004236354228864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004236409253888","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Uric Acid in the Follow-Up Determines 30% Decline in Estimated GFR Over 2 Years: a Propensity Score Analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004239493324672","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Urinary Angiotensinogen Could Be a Prognostic Marker of the Renoprotection of Olmesartan in Metabolic Syndrome Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360005515772270976","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360005518347767040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360005519862411648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renoprotective effects of sodium-glucose cotransporter-2 inhibitors and underlying mechanisms"}]},{"@id":"https://cir.nii.ac.jp/crid/1360005669431560448","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The role of oxidative stress and hypoxia in renal disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168789766912","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory <i>post hoc</i> analyses from FIDELIO-DKD compared to reported CREDENCE results"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168818265984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168867193344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renal, cardiovascular and safety outcomes of canagliflozin in patients with type 2 diabetes and nephropathy in East and South‐East Asian countries: Results from the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation Trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168882574720","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Total Nephron Number and Single-Nephron Parameters in Patients with IgA Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017279863407616","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Nephrons, podocytes and chronic kidney disease: Strategic antihypertensive therapy for renoprotection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017279869145344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Compared effectiveness of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on hyperkalemia in patients with chronic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017280636627840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Trends in the incidence of renal replacement therapy by type of primary kidney disease in Japan, 2006–2020"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021390765402368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Need to continue or discontinue RAS inhibitors as CKD stage advances? Any alternative?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025430186440064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Diabetic kidney disease: the kidney disease relevant to individuals with diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025430189383424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effect of finerenone on nephrotic syndrome in patients with diabetic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025431095305728","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Upregulation of Piezo2 and increased extracellular matrix protein in diabetic kidney disease mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283690982590208","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Diabetic nephropathy: protective factors and a new therapeutic paradigm"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283691768348544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Impact of visit-to-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283691793284864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"New short interfering RNA-based therapies for glomerulonephritis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283692012378368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Combined Angiotensin Inhibition in Diabetic Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693310940672","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283694802649728","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Angiotensin II- and Salt-Induced Kidney Injury through Rac1-Mediated Mineralocorticoid Receptor Activation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285705272814976","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Serum-Free Medium Enhances the Immunosuppressive and Antifibrotic Abilities of Mesenchymal Stem Cells Utilized in Experimental Renal Fibrosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706147096192","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Peroxisome proliferator-activated receptor α attenuates high-cholesterol diet-induced toxicity and pro-thrombotic effects in mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706195453056","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Brain natriuretic peptide as a potential novel marker of salt-sensitivity in chronic kidney disease patients without cardiac dysfunction"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706933285504","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effect of Low-Dose (1 mg/day) Pitavastatin on Left Ventricular Diastolic Function and Albuminuria in Patients With Hyperlipidemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285707006769792","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The Angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285707136806912","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"1-Methylnicotinamide ameliorates lipotoxicity-induced oxidative stress and cell death in kidney proximal tubular cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285708382319488","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619764675328","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643742748544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Incidence and factors associated with prescribing renin‐angiotensin‐system inhibitors in adult idiopathic nephrotic syndrome: A nationwide cohort study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298338422956928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cardiorenal protective effects of sodium-glucose cotransporter 2 inhibition in combination with angiotensin II type 1 receptor blockade in salt-sensitive Dahl rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298339692170368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Deficiency of the kidney tubular angiotensin II type1 receptor–associated protein ATRAP exacerbates streptozotocin-induced diabetic glomerular injury via reducing protective macrophage polarization"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298339714969984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Exploring molecular targets in diabetic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298345006025984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Empagliflozin in Patients with Chronic Kidney Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298754843593600","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298757192027648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Sodium-Glucose Cotransporter-2 Inhibitors—Miracle Drugs for the Treatment of Chronic Kidney Disease Irrespective of the Diabetes Status: Lessons from the Dedicated Kidney Disease-Focused CREDENCE and DAPA-CKD Trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298757437090688","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Updates for Cardio‐Kidney Protective Effects by Angiotensin Receptor‐Neprilysin Inhibitor: Requirement for Additional Evidence of Kidney Protection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302865546171904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Combined effects of blood pressure and glucose status on the risk of chronic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302865548705024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Casual Serum Triglyceride Concentrations and New-Onset Chronic Kidney Disease in the General Japanese Population: The Iki City Epidemiological Study of Atherosclerosis and Chronic Kidney Disease Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306904414532992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Treatment of chronic kidney disease in older populations"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306904420000640","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Recent Advances and Perspectives on the Use of Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Chronic Kidney Disease: A Review"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565165444364416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565166745174016","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Macrophage-derived exosomes induce inflammatory factors in endothelial cells under hypertensive conditions"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565166784039040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cardiovascular and renal protective role of angiotensin blockade in hypertension with advanced CKD: a subgroup analysis of ATTEMPT-CVD randomized trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565167561201536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168607571072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Heart angiotensin II-induced cardiomyocyte hypertrophy suppresses coronary angiogenesis and progresses diabetic cardiomyopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168945199744","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565169779367424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Liver Angiotensinogen Is the Primary Source of Renal Angiotensin II"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565170280250240","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Correlations Between Serum Bilirubin Levels and Diabetic Nephropathy Progression Among Japanese Type 2 Diabetic Patients: A Prospective Cohort Study (Diabetes Distress and Care Registry at Tenri [DDCRT 5])"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567180041401344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Higher pulse pressure predicts initiation of dialysis in Japanese patients with diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181219349504","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Genetic variant of the renin-angiotensin system and prevalence of type 2 diabetes mellitus: a modest but significant effect of aldosterone synthase"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181289200128","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Design and Rationale of Japanese Evaluation Between Formula of Azelnidipine and Amlodipine Add on Olmesartan to Get Antialbuminuric Effect Study (J-FLAG)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182220095616","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renal protection by sodium-glucose cotransporter 2 inhibitors and its underlying mechanisms in diabetic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567183418051584","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Hypertension with diabetes mellitus complications"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184118134016","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renoprotective effects of a dipeptidyl peptidase 4 inhibitor in a mouse model of progressive renal fibrosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184238072960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Characterization of dry skin associating with type 2 diabetes mellitus using a KK-<i>A<sup>y</sup></i>/TaJcl mouse model"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184627734016","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Angiotensin II receptor blocker attenuates PDGF-induced mesangial cell migration in a receptor-independent manner"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184628078080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Plasma B-type natriuretic peptide level predicts kidney prognosis in patients with predialysis chronic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184843868672","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567186354521472","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Angiotensin II Receptor Blocker Improves Tumor Necrosis Factor-a-Induced Cytotoxicity via Antioxidative Effect in Human Glomerular Endothelial Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567186750836224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567186803461632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567189410933248","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567189446769536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Stearoyl-CoA Desaturase-1 Protects Cells against Lipotoxicity-Mediated Apoptosis in Proximal Tubular Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360568471539592064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules"}]},{"@id":"https://cir.nii.ac.jp/crid/1360568619632516608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"microRNA Crosstalk Influences Epithelial-to-Mesenchymal, Endothelial-to-Mesenchymal, and Macrophage-to-Mesenchymal Transitions in the Kidney"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092423871232","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in <scp>CASSIOPEIR</scp> study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092695721344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Update on diagnosis, pathophysiology, and management of diabetic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118706715904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118719599744","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renoprotective effects of sodium glucose cotransporter 2 inhibitors in type 2 diabetes patients with decompensated heart failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118741058176","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Trajectories of kidney function in diabetes: a clinicopathological update"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579818114373760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Gut Microbial Changes in Diabetic db/db Mice and Recovery of Microbial Diversity upon Pirfenidone Treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580229824061696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A Narrative Review of Diabetic Kidney Disease: Previous and Current Evidence-Based Therapeutic Approaches"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580232389683968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Mineralocorticoid Receptor Antagonists for Preventing Chronic Kidney Disease Progression: Current Evidence and Future Challenges"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580232430596608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Angiotensin receptor blockade with olmesartan alleviates brain pathology in obese <scp>OLETF</scp> rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584339757262848","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Outcomes of discontinuing renin-angiotensin system inhibitors: a study protocol for conducting systematic review and meta-analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584340710392320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584341824040704","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Oxidative stress and the role of redox signalling in chronic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846640402454400","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Do Genetic Variants of the Renin-Angiotensin System Predict Blood Pressure Response to Renin-Angiotensin System–Blocking Drugs? A Systematic Review of Pharmacogenomics in the Renin-Angiotensin System"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846640753027072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Unique “delta lock” structure of telmisartan is involved in its strongest binding affinity to angiotensin II type 1 receptor"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846641088390528","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Autophagy: Emerging Therapeutic Target for Diabetic Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846641721726336","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Olmesartan improves endothelial function in hypertensive patients: link with extracellular superoxide dismutase"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846643598130176","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The Role of Autophagy in the Pathogenesis of Diabetic Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846644756107264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Obesity-Mediated Autophagy Insufficiency Exacerbates Proteinuria-induced Tubulointerstitial Lesions"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846645855274240","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Autophagy: A Novel Therapeutic Target for Diabetic Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848656086505728","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848656526348416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Angiotensin II type 1 receptor blockade ameliorates proteinuria in puromycin aminonucleoside nephropathy by inhibiting the reduction of NEPH1 and nephrin"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657245084800","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848658335650048","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"One-year effectiveness and safety of open-label losartan/hydrochlorothiazide combination therapy in Japanese patients with hypertension uncontrolled with ARBs or ACE inhibitors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567663406336","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567674531840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Treatment of Diabetic Kidney Disease: Current and Future"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593697630720","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Methods for detecting outlying regions and influence diagnosis in multi-regional clinical trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861286503004544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Analysis of eGFR index category and annual eGFR slope association with adverse clinical outcomes using real-world Japanese data: a retrospective database study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865816800068096","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Role of Inflammation in Progression of Chronic Kidney Disease in Type 2 Diabetes Mellitus: Clinical Implications"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869855137386368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Chronic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869855574668160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Efficacy of renin-angiotensin system inhibitors, calcium channel blockers, and diuretics in hypertensive patients with diabetes: subgroup analysis based on albuminuria in a systematic review and meta-analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1361975844284657664","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Synergistic Impact of Diabetes and Hypertension on the Progression and Distribution of Glomerular Histopathological Lesions"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204239716352","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Gene Polymorphisms of the Renin-Angiotensin-Aldosterone System and Angiotensin II Type 1-Receptor Activating Antibodies in Renal Rejection"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204270633472","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Current and future medical therapies for CKD (chronic kidney disease)"},{"@language":"ja","@value":"慢性腎臓病（ＣＫＤ）治療薬の現状と新たな可能性"},{"@language":"ja-Kana","@value":"マンセイ ジンゾウビョウ CKD チリョウヤク ノ ゲンジョウ ト アラタナ カノウセイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204271623040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"薬理ゲノミクス―血管障害　　４　　インスリン抵抗性による血管障害の細胞内情報伝達機構"},{"@language":"en","@value":"Intracellular signal transduction of vascular injury in insulin resistance"},{"@value":"インスリン抵抗性による血管障害の細胞内情報伝達機構"},{"@language":"ja-Kana","@value":"インスリン テイコウセイ ニ ヨル ケッカン ショウガイ ノ サイボウ ナイジョウホウ デンタツ キコウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204274704384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"In vitro and in vivo pharmacological profiles of a novel angiotensin type 1–receptor blocker, azilsartan"},{"@language":"ja","@value":"新規アンジオテンシンAT<sub>1</sub>受容体ブロッカー アジルサルタンのinvitroおよびinvivo薬理作用"},{"@value":"新規アンジオテンシンAT₁受容体ブロッカー アジルサルタンのin vitroおよびin vivo薬理作用"},{"@language":"ja-Kana","@value":"シンキ アンジオテンシン AT ₁ ジュヨウタイ ブロッカー アジルサルタン ノ in vitro オヨビ in vivo ヤクリ サヨウ"},{"@value":"In vitro and in vivo pharmacological profiles of a novel angiotensin type 1^|^ndash;receptor blocker, azilsartan"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204340282368","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Intrarenal renin-angiotensin system activation and urinary angiotensinogen as a novel biomarker of nephropathy in childhood"},{"@value":"腎内レニン・アンジオテンシン系活性化と尿中アンジオテンシノーゲン"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204432185472","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of Lipid-Lowering Therapy with Rosuvastatin on Kidney Function and Oxidative Stress in Patients with Diabetic Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204472383104","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"開発環境：医薬品開発の現状と課題"},{"@language":"en","@value":"The Issues on the Research and Development Strategies of New Drugs"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204627349504","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Roles of Coagulation Pathway and Factor Xa in the Progression of Diabetic Nephropathy in db/db Mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204677569536","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"１．　レニン・アンジオテンシン（ＲＡＳ）系抑制薬による透析患者の心血管病抑制効果"},{"@value":"レニン・アンジオテンシン(RAS)系抑制薬による透析患者の心血管病抑制効果"},{"@language":"ja-Kana","@value":"レニン ・ アンジオテンシン(RAS)ケイ ヨクセイヤク ニ ヨル トウセキ カンジャ ノ シンケツカンビョウ ヨクセイ コウカ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204719667584","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Vasoconstricting Effect of Angiotensin II in Human Hand Veins: Influence of Aging, Diabetes Mellitus and Hypertension."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204719674624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The Status of Hypertension Management in Japan in 2000."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204719982848","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Trends in Blood pressure Control in Hypertensive Patients with Diabetes Mellitus in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204720034176","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients: Rationale, Design, and Methods"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204720870272","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Antiproteinuric Effects of Combined Antihypertensive Therapies in Patients with Overt Type 2 Diabetic Nephropathy."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204720881408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Selection of the Dose of Angiotensin Converting Enzyme Inhibitor for Patients with Diabetic Nephropathy Depends on the Presence or Absence of Left Ventricular Hypertorphy."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204721268224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"<B>Differing Anti-Proteinuric Action of Candesartan and Losartan in Chronic Renal Disease</B>"},{"@value":"Differing Anti-Proteinuric Action of Candesartan and Losartan in Chronic Renal Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204721300992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Remission and Regression of Diabetic Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204795489664","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Management of the Liver Transplant Recipients in the Stable-Phase"},{"@language":"ja","@value":"肝移植後安定期における内科的管理－Ｃａｌｃｉｎｅｕｒｉｎ　ｉｎｈｉｂｉｔｏｒによる管理を中心に－"},{"@language":"ja-Kana","@value":"カン イショクゴ アンテイキ ニ オケル ナイカテキ カンリ Calcineurin inhibitor ニ ヨル カンリ オ チュウシン ニ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204836578176","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"高血圧併用療法とCOPE Trial"},{"@language":"en","@value":"Evidence for the Treatment of Hypertension with Combination Therapy and the COPE Trial"},{"@language":"ja-Kana","@value":"コウケツアツ ヘイヨウ リョウホウ ト COPE Trial ミニ レビュー コニシショウ ジュショウシャ"},{"@value":"小西賞受賞者 高血圧併用療法とCOPE Trial"},{"@language":"ja-Kana","@value":"コニシショウ ジュショウシャ コウケツアツ ヘイヨウ リョウホウ ト COPE Trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204859124224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Renoprotective effect of triple therapy with low-dose angiotensin receptor blocker, low-dose diuretic and Ca-antagonist in hypertensive type 2 diabetic patients with overt nephropathy"},{"@value":"糖尿病性腎症に対する低用量アンジオテンシンＩＩ受容体きっ抗薬／低用量利尿薬／カルシウムきっ抗薬の三剤併用療法の腎保護作用"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204860491136","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Salt intake and the progression of chronic renal diseases"},{"@value":"慢性腎疾患における減塩の腎障害進展に及ぼす影響"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204861213952","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"糖尿病性腎症　　糖尿病性腎症治療におけるＲＡＳ阻害薬の新展開"},{"@language":"en","@value":"Special Issue: Diabetic Nephropathy—New findings with RAS inhibitors in diabetic nephropathy"},{"@language":"ja-Kana","@value":"トウニョウビョウセイ ジンショウ チリョウ ニ オケル RAS ソガイヤク ノ シンテンカイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204861803136","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Suppressive effect of angiotensin converting enzyme inhibitor (ACEI) on the progression of renal insufficiency: a propensity score analysis"},{"@value":"アンジオテンシン変換酵素阻害薬長期投与における腎障害進行の抑制効果―Ｐｒｏｐｅｎｓｉｔｙ　Ｓｃｏｒｅによる検討"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204863301632","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Self-Assessment Program"},{"@value":"腎臓専門医の研修単位認定のためのセルフトレーニング問題の正解と解説"},{"@language":"ja-Kana","@value":"ジンゾウ センモンイ ノ タメ ノ セルフ アセスメント プログラム ジンゾウ センモンイ ノ ケンシュウ タンイ ニンテイ ノ タメ ノ セルフトレーニング モンダイ ノ セイカイ ト カイセツ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204867571712","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Detective Story for Biomedical Footprints towards New Therapeutic Interventions in Diabetic Nephropathy"},{"@language":"ja-Kana","@value":"Detective Story for Biomedical Footprints towards New Therapeutic Interventions in Diabetic Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204867828608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Progression of Renal Failure Delayed by Use of Losartan in a Case of IgA Nephropathy."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204868817792","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"New Aspects of Renal Diseases-From Urine Checkup to Kidney Transplantation-1. Renal Screening Tests"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204870104448","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Do Angiotensin-converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Have Similar Effects in the Improvement of Left Ventricular Dysfunction after Myocardial Infarction in Japanese?"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204871751808","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of Olmesartan, an Angiotensin II Receptor Blocker, on Peripheral Insulin Sensitivity in Japanese Subjects with Type 2 Diabetes and Hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204872196352","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Analysis of Factors Causing Hyperkalemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204872230016","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Long-term Renal Prognosis of IgA Nephropathy with Therapeutic Trend Shifts"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204873665280","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Increased Risk of Renal Deterioration Associated with Low e-GFR in Type 2 Diabetes Mellitus Only in Albuminuric Subjects"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204874851840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"慢性腎臓病の治療総論（降圧療法，食事療法を含めて）"},{"@language":"en","@value":"Introduction to chronic kidney disease treatment : Anti-hypertensive and dietary treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204904804608","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"糖尿病治療に関わる大規模臨床試験　　糖尿病患者の高血圧治療"},{"@language":"ja-Kana","@value":"トウニョウビョウ カンジャ ノ コウケツアツ チリョウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204905127296","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"糖尿病罹病期間30年で集学的治療にて寛解した糖尿病性腎症の1例"},{"@language":"en","@value":"Remission of Nephropathy due to Multifactorial Treatment in a Patient with Long-Standing Diabetes of over 30 Years' Duration"},{"@value":"症例報告 糖尿病罹病期間30年で集学的治療にて寛解した糖尿病性腎症の1例"},{"@language":"ja-Kana","@value":"ショウレイ ホウコク トウニョウビョウ リビョウ キカン 30ネン デ シュウガクテキ チリョウ ニテ カンカイシタ トウニョウビョウセイ ジンショウ ノ 1レイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204905128960","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"厳格な血圧管理による顕性糖尿病性腎症における尿蛋白量の減少効果"},{"@language":"en","@value":"Strict Blood Pressure Control Reduces Urinary Protein Excretion in Patients with Overt Diabetic Nephropathy"},{"@language":"ja-Kana","@value":"ゲンカクナ ケツアツ カンリ ニ ヨル ケンセイ トウニョウビョウセイ ジンショウ ニ オケル ニョウ タンパクリョウ ノ ゲンショウ コウカ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205056451072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Changes in renal vessels associated with long-term administration of          angiotensin converting enzyme inhibitor in Zucker fatty rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205102686464","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Proposed New Score to Rate the Strength of Evidence and Its Application to Large-Scale Clinical Trials of Angiotensin-Receptor Blockers"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205106704896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Influence of Left Ventricular Ejection Fraction on the Effects of Supplemental Use of Angiotensin Receptor Blocker Olmesartan in Hypertensive Patients With Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205225086336","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pleiotropic Effects of Angiotensin II Receptor Signaling in Cardiovascular Homeostasis and Aging"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205225495168","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Combination of Antihypertensive Therapy in The Elderly, Multicenter Investigation (CAMUI) Trial"},{"@value":"for the CAMUI investigatorsCombination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial: rationale and design."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205339771776","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Uricosuric Effects of Angiotensin II Receptor Antagonists in the Patients With Normal Renal Function"},{"@value":"正常腎機能患者におけるアンジオテンシンＩＩ受容体きっ抗薬の血清尿酸値への影響"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205746588544","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A overview of Hemodialysis Therapy in our Insititution Between 1980 and 2008"},{"@language":"ja","@value":"順天堂医院腎・高血圧内科における血液透析療法の検討"},{"@language":"ja-Kana","@value":"ジュン テンドウ イインジン コウケツアツ ナイカ ニ オケル ケツエキ トウセキ リョウホウ ノ ケントウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205746813056","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Japan-Indonesia Collaborative Study of Imidapril on Antiproteinuric Effect in Hypertensive Patients with Chronic Kidney Disease (CKD)"},{"@language":"ja","@value":"CKD 患者におけるイミダプリルの尿蚕白減少効果 (日本-インドネシア共同研究)"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205747670528","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Role of renin angiotensin system in pathogenesis of glomerulonephritis"},{"@language":"ja","@value":"レニン・アンジオテンシン系の糸球体腎炎における役割"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206129153920","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"循環器領域における多国籍臨床試験"},{"@language":"en","@value":"Multi-National Clinical Trial in Circulatory Disorders"},{"@language":"ja-Kana","@value":"ジュンカンキ リョウイキ ニ オケル タコクセキ リンショウ シケン"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206339628160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Deterioration of Retinopathy After Starting Interferon Therapy for Chronic Hepatitis C with Diabetic Triopathy."},{"@value":"症例報告 Deterioration of Retinopathy After Starting Interferon Therapy for Chronic Hepatitis C with Diabetic Triopathy"},{"@language":"ja-Kana","@value":"ショウレイ ホウコク Deterioration of Retinopathy After Starting Interferon Therapy for Chronic Hepatitis C with Diabetic Triopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206427690752","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of Benazepril Hydrochloride in Cats with Experimentally Induced or Spontaneously Occurring Chronic Renal Failure"},{"@language":"ja","@value":"ネコの実験的慢性腎不全モデルおよび自然発症慢性腎不全に対するbenazepril hydrochlorideの効果"},{"@value":"Internal medicine: Effects of benazepril hydrochloride in cats with experimentally induced or spontaneously occurring chronic renal failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206440392960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Report on a pending question 3.  Diabetic nephropathy - Base and clinical advance -."},{"@value":"宿題報告　　３．糖尿病性腎症―基礎と臨床の進歩―"},{"@language":"ja-Kana","@value":"シュクダイ ホウコク トウニョウビョウセイジンショウ : キソ ト リンショウ ノ シンポ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206440626304","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Diabetic nephropathy."},{"@value":"糖尿病性腎症の基礎と臨床"},{"@language":"ja","@value":"3.糖尿病性賢症の基礎と臨床"},{"@language":"ja-Kana","@value":"シュクダイ ホウコク トウニョウビョウセイジンショウ ノ キソ ト リンショウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206441335680","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"血液疾患および腎臓疾患の診断と治療の進歩　　７．保存期腎不全の治療戦略"},{"@language":"ja-Kana","@value":"ホゾンキ ジンフゼン ノ チリョウ センリャク"},{"@language":"en","@value":"[Therapeutic strategy for patients with stable-stage chronic kidney failure]."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206441367808","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"血液疾患および腎臓疾患の診断と治療の進歩　　９．腎性高血圧の診断と治療"},{"@language":"ja-Kana","@value":"ジンセイ コウケツアツ ノ シンダン ト チリョウ"},{"@language":"en","@value":"[Diagnosis of and therapy for renal hypertension]."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206441585280","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"メタボリックシンドロームの定義と診断基準"},{"@language":"ja-Kana","@value":"メタボリックシンドローム ノ テイギ ト シンダン キジュン"},{"@language":"en","@value":"[Definition and the diagnostic standard for metabolic syndrome--Committee to Evaluate Diagnostic Standards for Metabolic Syndrome]."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206441621120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"腎疾患―検診から移植まで　　１）検診"},{"@language":"ja-Kana","@value":"ケンシン"},{"@language":"en","@value":"[Proper use of antibiotics and related guidelines. The future image for the guidelines--global or regional standard?]."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206442185600","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"内科　　１００年のあゆみ　　腎臓　Ｉ　　腎臓領域の１００年　６　　腎臓学における「Ｈｙｐｅｒｆｉｌｔｒａｔｉｏｎ　ｔｈｅｏｒｙ」の意義"},{"@language":"ja-Kana","@value":"ジンゾウガク ニ オケル 「 Hyperfiltration theory 」 ノ イギ"},{"@language":"en","@value":"[History of nephrology in the past 100 years: Significance of hyperfiltration theory in the nephrology]."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206442729088","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"内科　　１００年のあゆみ　　腎臓　　診療ガイドラインレビュー　２　　糖尿病性腎症"},{"@language":"ja-Kana","@value":"トウニョウビョウセイジンショウ"},{"@language":"en","@value":"[Clinical guideline review: Diabetic nephropathies]."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206442942848","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"全身性疾患と腎病変：診断と治療の進歩　　ＩＩ．代謝性疾患　　１．糖尿病"},{"@language":"ja-Kana","@value":"トウニョウビョウ"},{"@language":"en","@value":"[Diabetes mellitus]."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206444736768","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Metabolic Domino and CKD."},{"@language":"ja","@value":"メタボリックドミノとCKD"},{"@value":"医学と医療の最前線 メタボリックドミノとCKD"},{"@language":"ja-Kana","@value":"イガク ト イリョウ ノ サイゼンセン メタボリックドミノ ト CKD"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206447116160","@type":"Article","resourceType":"other","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"2. Therapeutic Strategy for Diabetic Nephropathy"},{"@language":"ja","@value":"2．糖尿病腎症に対する治療戦略"},{"@value":"教育講演 糖尿病腎症の治療戦略"},{"@language":"ja-Kana","@value":"キョウイク コウエン トウニョウビョウジンショウ ノ チリョウ センリャク"}]},{"@id":"https://cir.nii.ac.jp/crid/1390011108724264960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Challenges in drug discovery research and the effects of SGLT2 inhibitor against diabetic kidney disease"},{"@language":"ja","@value":"糖尿病性腎臓病に対する創薬研究の取り組みとSGLT2阻害薬による病態進展抑制の可能性"}]},{"@id":"https://cir.nii.ac.jp/crid/1390020209538083840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Impact of Age on Prescribing Patterns of Cardiovascular Medications in Older Japanese Patients with Non-Dialysis-Dependent Chronic Kidney Disease: A Cross-Sectional Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679216725376","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Losartan, an Angiotensin-II Receptor Antagonist, Retards the Progression of Advanced Renal Insufficiency"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679408488576","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Current Trends in Lifestyle-Related Disease Management by General Practitioners: A Report from the “Heart Care Network” Groups"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679409119360","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Association and Prognostic Impact of Heart Rate and Micro- Albuminuria in Patients with Type 2 Diabetes and Cardiovascular Disease: Results from the PROactive Trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679422584960","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Microalbuminuria in intensive care unit"},{"@language":"ja","@value":"集中治療と尿中微量アルブミン"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679605182592","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Combination Therapy with SMP-534 and an Angiotensin-Converting Enzyme Inhibitor Provides Additional Renoprotection in 5/6 Nephrectomized Rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679651696640","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"糖尿病性腎症の病態と新たな創薬に向けて―第４９回日本透析医学会教育講演より―"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679696810624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Trends in Pharmacologic Management of Hypertension in Japan One Year after the Publication of the JSH 2000 Guidelines."}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679696932352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Renoprotective Effects of Blockade of Angiotensin II AT1 Receptors in an Animal Model of Type 2 Diabetes."},{"@value":"Renoprotective effect of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679697288576","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Case of Nephrotic Syndrome Associated with Renovascular Hypertension Successfully Treated with Candesartan."}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679697356032","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Regulation of Glucose Transporter (GLUT1) Gene Expression by Angiotensin II in Mesangial Cells: Involvement of HB-EGF and EGF Receptor Transactivation."}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679697527296","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Comparison between Cilnidipine and Amlodipine Besilate with Respect to Proteinuria in Hypertensive Patients with Renal Diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679697620352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Successful Treatment of Severe Hypertension with the Combination of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679697626240","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Renoprotective Effect of Losartan in Comparison to Amlodipine in Patients with Chronic Kidney Disease and Hypertension-a Report of the Japanese Losartan Therapy Intended for the Global Renal Protection Hypertensive Patients (JLIGHT) Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679753118464","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of Candesartan Cilexetil on Urinary Protein Excretion in Patients with Essential Hypertension."},{"@language":"ja","@value":"カンデサルタンシレキセチルが本態性高血圧患者の尿中蛋白排泄に与える影響"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679837843456","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"腎臓学この一年の進歩　　臨床腎臓学"},{"@language":"en","@value":"Clinical nephrology"},{"@language":"ja-Kana","@value":"リンショウ ジンゾウガク"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679839816704","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"腎移植の現状：総合的腎不全治療のあり方―医療の根本は奉仕であることを忘れてはならない―"},{"@language":"en","@value":"Review: Kidney Transplantation Series"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679842797824","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Fiveyear Comparison of the Renal Protective Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with NonDiabeticNephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679845530368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"2. Importance of Early Detection and Diagnosis for Kidney Diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679847536384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Prevalence of Chronic Kidney Disease and Blood Pressure Control Status in Elderly Hypertensive Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679847791616","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinical Pathology and Treatment of Renin-Angiotensin System 2. Chronic Kidney Disease and the Renin-Angiotensin System"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679849555584","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Long-Term Intensive Insulin Therapy for Japanese Patients with Type 2 Diabetes Mellitus"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679852145280","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"糖尿病患者における血圧管理"},{"@language":"en","@value":"Control of blood pressure in diabetic patients"},{"@value":"ガイドライン 糖尿病患者における血圧管理"},{"@language":"ja-Kana","@value":"ガイドライン トウニョウビョウ カンジャ ニ オケル ケツアツ カンリ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680063201024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"Continuous Glucose Monitoring（CGM）を用いた2型糖尿病患者の糖尿病細小血管合併症と血糖変動との関連"},{"@language":"en","@value":"Association Between Diabetic Microangiopathies and Glycemic Variability Assessed by Continuous Glucose Monitoring"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680071460608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Beraprost Sodium Protects Against Diabetic Nephropathy in Patients with Arteriosclerosis Obliterans: A Prospective, Randomized, Open-label Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680078502400","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Demographics and Changes in Medical/Interventional Treatment of Coronary Artery Disease Patients Over a 3.5-Year Period in Japan  The Japanese Coronary Artery Disease Study: Trend Examination"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680155610752","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Losartan Normalizes Endothelium-Derived Hyperpolarizing Factor-Mediated Relaxation by Activating Ca2+-Activated K+ Channels in Mesenteric Artery From Type 2 Diabetic GK Rat"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680155737984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Renin–Angiotensin System, Hypertension, and Chronic Kidney Disease: Pharmacogenetic Implications"},{"@value":"Renin^|^ndash;Angiotensin System, Hypertension, and Chronic Kidney Disease: Pharmacogenetic Implications"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680156321536","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System: Evidence From Randomized Controlled Trials (RCTs) of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II-Receptor Blockers - Questions Remain Unsolved"},{"@value":"Evidence from randomized controlled trials (RCTs) of angiotensin-converting enzyme inhibitors and angiotensin 2-receptor blockers: questions remain unsolved"},{"@value":"New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Evidence From Randomized Controlled Trials (RCTs) of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II–Receptor Blockers — Questions Remain Unsolved"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680156740736","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Olmesartan Inhibits Angiotensin II-Induced Migration of Vascular Smooth Muscle Cells Through Src and Mitogen-Activated Protein Kinase Pathways"},{"@value":"Olmesartan inhibits angiotensin 2-induced migration of vascular smooth muscle cells through Src and mitogen-activated protein kinase pathways"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680156875008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Urinary Angiotensinogen as a Novel Early Biomarker of Intrarenal Renin–Angiotensin System Activation in Experimental Type 1 Diabetes"},{"@value":"Urinary Angiotensinogen as a Novel Early Biomarker of Intrarenal Renin^|^ndash;Angiotensin System Activation in Experimental Type 1 Diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680201841280","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Combination Therapy With Telmisartan and Spironolactone Alleviates L-NAME Exacerbated Nephrosclerosis With an Increase in PPAR-.GAMMA.  and Decrease in TGF-.BETA.1"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680344859776","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"臨床試験のエンドポイントの新しい方向性：合併症予防から原疾患の発症予防へ　　５．レニン‐アンジオテンシン系阻害剤による腫瘍抑制"},{"@language":"en","@value":"5. Chemoprevention by Inhibitory Drugs of Renin-Angiotensin System"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680492892288","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Paradigm Shift for the Concept of Diabetic Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681193959040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The Survey of the Compliance Situation to the Antihypertensive Therapy Guideline by Analyzing Japanese National Claims Data"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681274932736","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Characterization of Plasma Brain Natriuretic Peptide Level in Patients with Type 2 Diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681277308672","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Progression of Diabetic Nephropathy Enhances the Plasma Osteopontin Level in Type 2 Diabetic Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681277443712","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Dual Blockade of Angiotensin II with Enalapril and Losartan Reduces Proteinuria in Hypertensive Patients with Type 2 Diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681407330816","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Development of Hypertension and Effects of Benazepril Hydrochloride in a Canine Remnant Kidney Model of Chronic Renal Failure"},{"@language":"ja","@value":"イヌの実験的慢性腎不全モデルにおける高血圧の発現とBenazepril Hydrochlorideの効果"},{"@value":"Internal medicine: Development of hypertension and effects of benazepril hydrochloride in a canine remnant kidney model of chronic renal failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681411170944","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"アンジオテンシンII 受容体拮抗薬"},{"@language":"en","@value":"The Recent Trends in the Use of Angiotensin II Receptor Blockers"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681418045056","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"血液疾患および腎臓疾患の診断と治療の進歩　　６．糖尿病性腎症の早期診断と治療"},{"@language":"ja-Kana","@value":"トウニョウビョウセイジンショウ ノ ソウキ シンダン ト チリョウ"},{"@language":"en","@value":"[Early diagnosis of and therapy for patients with diabetic nephropathy]."}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681418068864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"高血圧治療－ＪＳＨ２０００以後のエビデンスを含めて"},{"@language":"ja-Kana","@value":"コウケツアツ チリョウ : JSH2000 イゴ ノ エビデンス オ フクメテ"},{"@language":"en","@value":"[Evidence-based therapy for patients with hypertension following JSH2000 guidelines]."}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681418364032","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Hypertension. Medical care from the viewpoint of evidence. II. Treatment. 4. Treatment of diabetes mellitus complicated hypertension."},{"@value":"高血圧　　エビデンスからみた診療　ＩＩ　　治療　４　　糖尿病合併高血圧の治療"},{"@language":"ja-Kana","@value":"トウニョウビョウ ガッペイ コウケツアツ ノ チリョウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681418407680","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Kidney and hypertension: Forefronts of evidence-based therapy."},{"@value":"腎と高血圧：エビデンスに基づいた治療の最前線"},{"@language":"ja-Kana","@value":"イガク ト イリョウ ノ サイゼンセン ジン ト コウケツアツ : エビデンス ニ モトズイタ チリョウ ノ サイゼンセン"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681418999040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"水・電解質異常―管理の実際　　ＩＩ．　症候の評価と治療の実際（水・電解質管理）　　８．　高齢者の水・電解質異常の特徴と管理"},{"@language":"ja-Kana","@value":"コウレイシャ ノ ミズ ・ デンカイシツ イジョウ ノ トクチョウ ト カンリ"},{"@language":"en","@value":"[Management of water electrolyte imbalance in aged patients]."}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681419474816","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"内科　　１００年のあゆみ　　腎臓　ＩＩＩ　　主要疾患の歴史　２　　慢性腎不全"},{"@language":"ja-Kana","@value":"マンセイ ジンフゼン"},{"@language":"en","@value":"[History of nephrology in the past 100 years: Chronic kidney failure]."}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681422129024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"4．高血圧"},{"@language":"en","@value":"4. Hypertension"},{"@value":"高血圧"},{"@language":"ja-Kana","@value":"コウケツアツ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681525124352","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"慢性腎臓病 (CKD) と栄養"},{"@language":"en","@value":"The Optimal Reason for Diet Control in the Treatment of Chronic Kidney Disease (CKD)"},{"@value":"慢性腎臓病(CKD)と栄養--慢性腎臓病(CKD)の最適治療に何故食事療法が必要か"},{"@language":"ja-Kana","@value":"マンセイ ジンゾウビョウ CKD ト エイヨウ マンセイ ジンゾウビョウ CKD ノ サイテキ チリョウ ニ ナゼ ショクジ リョウホウ ガ ヒツヨウ カ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390285300180135040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Paradigm Shift in the Treatment of Type 2 Diabetes and Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390301452272606720","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"6. The Progress in the Therapy for Diabetic Kidney Disease"},{"@language":"ja","@value":"6）糖尿病性腎臓病の治療の進歩"}]},{"@id":"https://cir.nii.ac.jp/crid/1390566775151600384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Lipoprotein (a) and the Risk of Chronic Kidney Disease in Hospitalized Japanese Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1390573715160688896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Low plasma renin activity is independently associated with kidney disease progression in patients with type 2 diabetes and overt nephropathy, including those with impaired kidney function: a 2-year prospective study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390585636768982016","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"エビデンスに基づいた糖尿病と糖尿病性腎症の診断と治療"},{"@language":"en","@value":"Diagnosis and Therapy of Diabetes Based on Evidence"}]},{"@id":"https://cir.nii.ac.jp/crid/1390865643808361600","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Conceptualizing Treatment Strategies for Diabetic Kidney Disease: the          Importance of Early Diagnosis and Treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1391131406293094272","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Diagnosis, Prevention, and Treatment of Cardiovascular Diseases in People With Type 2 Diabetes and Prediabetes　― A Consensus Statement Jointly From the Japanese Circulation Society and the Japan Diabetes Society ―"}]},{"@id":"https://cir.nii.ac.jp/crid/1391693801403136640","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Changes over the past 33 Years at Urayasu Hospital"}]},{"@id":"https://cir.nii.ac.jp/crid/1520009409335908224","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"保存期腎不全の治療"},{"@language":"ja-Kana","@value":"ホゾンキ ジンフゼン ノ チリョウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1520009409704720640","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"腎臓分野"},{"@language":"ja-Kana","@value":"ジンゾウ ブンヤ"}]},{"@id":"https://cir.nii.ac.jp/crid/1520290882202679936","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"保存期慢性腎不全における低蛋白食としての高カロリー低蛋白クッキー(RKF-1)の有用性の可能について"},{"@language":"ja-Kana","@value":"ホゾンキ マンセイ ジンフゼン ニ オケル テイタンパクショク ト シテノ コウカロリー テイタンパク クッキー RKF 1 ノ ユウヨウセイ ノ カノウ ニ ツイテ"}]},{"@id":"https://cir.nii.ac.jp/crid/1520290883778384512","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"糖尿病性腎症患者におけるアンジオテンシン変換酵素阻害薬とアンジオテンシンⅡ受容体拮抗薬併用療法の有効性の検討"},{"@language":"ja-Kana","@value":"トウニョウビョウセイジンショウ カンジャ ニ オケル アンジオテンシン ヘンカン コウソ ソガイヤク ト アンジオテンシン Ⅱ ジュヨウタイ キッコウヤク ヘイヨウ リョウホウ ノ ユウコウセイ ノ ケントウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1520573330386171264","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"Combinational effect of genes for the renin-angiotensin system in conferring susceptibility to diabetic nephropathy"},{"@language":"ja-Kana","@value":"Combinational effect of genes for the renin angiotensin system in conferring susceptibility to diabetic nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1520853832987995136","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"糖尿病性腎症 : 進展因子と対策"},{"@language":"ja-Kana","@value":"トウニョウビョウセイジンショウ : シンテン インシ ト タイサク"}]},{"@id":"https://cir.nii.ac.jp/crid/1520853833157432192","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"第128回東邦医学会例会:特別講演 糖尿病性腎症概説"},{"@language":"ja-Kana","@value":"ダイ128カイ トウホウ イガクカイ レイカイ トクベツ コウエン トウニョウビョウセイジンショウ ガイセツ"}]},{"@id":"https://cir.nii.ac.jp/crid/1522543654949889152","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"高血圧の薬物療法"},{"@language":"ja-Kana","@value":"コウケツアツ ノ ヤクブツ リョウホウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1524232504994281600","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"高血圧の診断・管理・治療の最近の動向--新しいガイドラインについて"},{"@language":"ja-Kana","@value":"コウケツアツ ノ シンダン カンリ チリョウ ノ サイキン ノ ドウコウ アタラシイ ガイドライン ニ ツイテ"}]},{"@id":"https://cir.nii.ac.jp/crid/1570009749799452032","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"糖尿病性細小血管症の予防"},{"@language":"en","@value":"Prevention of Diabetic Microangiopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1570009750586633344","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Improvement of Blood Pressure Control in Hypertensive Patients with Renal Diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1570291225544561664","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Design and Baseline Characteristics of an Observational Study in Japanese Patients with Hypertension : Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH)"}]},{"@id":"https://cir.nii.ac.jp/crid/1570291225911203456","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1570572700242775680","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of Valsartan on the Progression of Chronic Renal Insufficiency in Patients with Nondiabetic Renal Diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1570572700887064192","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Treatment of type 2 diabetic patients with kidney disease with AT_1-receptor antagonists : lessons from recent trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1570854175479476480","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"腎症を合併する2型糖尿病に対するアンジオテンシンII受容体拮抗薬の医療経済評価"},{"@language":"en","@value":"HEALTH ECONOMICS OF USE OF ANGIOTENSIN-II-RECEPTOR BLOCKER IN THE PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY"}]},{"@id":"https://cir.nii.ac.jp/crid/1570854175497983104","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Renal-Protective Effect of T- and L-Type Calcium Channel Blockers in Hypertensive Patients : An Amlodipine-to-Benidipine Changeover (ABC) Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1570854175863154176","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"降圧薬の現況"}]},{"@id":"https://cir.nii.ac.jp/crid/1570854176756487552","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Acute renal failure due to cholesterol crystal embolism treated with LDL apheresis followed by corticosteroid and candesartan"}]},{"@id":"https://cir.nii.ac.jp/crid/1571135650488439296","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Antihypertensive Efficacy and Safety of Fixed-Dose Combination Therapy with Losartan plus Hydrochlorothiazide in Japanese Patients with Essential Hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1571417125201467904","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"糖尿病網膜症, 黄斑症の病態の新しい見方 : 薬物療法を目指して"},{"@language":"en","@value":"New Findings in Pathogenesis of Diabetic Retinopathy and Maculopathy Aiming for Drug Treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1571698600316873472","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Renal and Vascular Protective Effects of Telmisartan in Patients with Essential Hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1571698601692143872","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension : a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1571980074857968768","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"慢性糸球体腎炎患者に対する Angiotensin-Converting Enzyme Inhibitor と Angiotensin Il Receptor Blocker の併用による抗蛋白尿効果"},{"@language":"en","@value":"Additive antiproteinuric effect of angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis"}]},{"@id":"https://cir.nii.ac.jp/crid/1571980075002289664","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"最近の高血圧治療のレビュー"}]},{"@id":"https://cir.nii.ac.jp/crid/1572261550185668096","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Blood Pressure Reduction and Cardiovascular Prevention : An Update Including the 2003-2004 Secondary Prevention Trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1572261550185741952","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"An Angiotensin Receptor Blocker Reduces the Risk of Congestive Heart Failure in Elderly Hypertensive Patients with Renal Insufficiency"}]},{"@id":"https://cir.nii.ac.jp/crid/1572261550400347776","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of Monotherapy of Temocapril or Candesartan with Dose Increments or Combination Therapy with Both Drugs on the Suppression of Diabetic Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1572261550748129024","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Dual blockade of the renin-angiotensin system in chronic renal disease : to do or not to do"}]},{"@id":"https://cir.nii.ac.jp/crid/1572543025725387008","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"高度腎機能低下例に対するアンジオテンシンII受容体拮抗薬(ロサルタン)の腎機能, 血清カリウム値, 血圧に対する影響 : 血清クレアチニン値が3.0mg/dl以上と未満の患者での違いについて"},{"@language":"en","@value":"Effect of angiotensin II receptor antagonist (losartan) on renal function, serum potassium and blood pressure in patients with advanced renal failure : differences between patients with a serum creatinine(SCr) level higher than 3 mg/dl and those with a lower SCr level"}]},{"@id":"https://cir.nii.ac.jp/crid/1572824499932491392","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"カンデサルタンシレキセチル"}]},{"@id":"https://cir.nii.ac.jp/crid/1572824501593463424","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Treatment of diabetic nephropathy with angiotensin II receptor antagonist"}]},{"@id":"https://cir.nii.ac.jp/crid/1572824501602439936","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1573105974738087552","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The rising tide of end-stage renal disease : what can be done?"}]},{"@id":"https://cir.nii.ac.jp/crid/1573105975307610752","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"白血球単核球分画におけるキマーゼ依存性アンジオテンシンII産生活性と血中コレステロール値との相関"},{"@language":"en","@value":"Positive Correlation Between Chymase-Like Angiotensin II-Forming Activity in Mononuclear Cells and Serum Cholesterol Level"}]},{"@id":"https://cir.nii.ac.jp/crid/1573105975334235648","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Is Renoprotection by Angiotensin Receptor Blocker Dependent on Blood Pressure? : The Saitama Medical School, Albuminuria Reduction in Diabetics with Valsartan (STAR) Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1573387449871283968","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"腎臓病医による長期腎不全治療が奏効すると腎不全進行を緩徐にするだけでなく晩期透析導入が可能となる : 第48回日本透析医学会コントラバシィより"}]},{"@id":"https://cir.nii.ac.jp/crid/1573387449885613056","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"腎疾患合併症のある高血圧の治療"}]},{"@id":"https://cir.nii.ac.jp/crid/1573387449907834496","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"糖尿病性腎症の病期と発生予知"},{"@language":"en","@value":"Diabetic Nephropathy ; Clinical Stage and Prediction"}]},{"@id":"https://cir.nii.ac.jp/crid/1573387449985374592","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort"}]},{"@id":"https://cir.nii.ac.jp/crid/1573387450171456512","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Changes in the Demographics and Prevalence of Chronic Kidney Disease in Okinawa, Japan (1993 to 2003)"}]},{"@id":"https://cir.nii.ac.jp/crid/1573387450276913280","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD)"}]},{"@id":"https://cir.nii.ac.jp/crid/1573668924680951936","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Therapeutic effects of long-term administration of an oral adsorbent in patients with chronic renal failure : two-year study"}]},{"@id":"https://cir.nii.ac.jp/crid/1573668924870660224","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"アンジオテンシンII受容体拮抗薬により蛋白尿減少効果と腎機能改善がみられた巣状糸球体硬化症の3例"},{"@language":"en","@value":"Angiotensin type 1 receptor blocker reduced proteinuria in patients of focal glomerular sclerosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1573668924962274688","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Factors influencing the development of end-stage renal disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1573668925283041536","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Olmesartan Reducing Incidence of Endstage Renal Disease in Diabetic Nephropathy Trial (ORIENT) : Rationale and Study Design"}]},{"@id":"https://cir.nii.ac.jp/crid/1573950399893380864","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"ロサルタン : アンジオテンシンII受容体拮抗薬の特徴と降圧療法における位置づけ"}]},{"@id":"https://cir.nii.ac.jp/crid/1573950400255650176","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Angiotensin Receptor Blocker Improves Coronary Flow Velocity Reserve in Hypertensive Patients : Comparison with Calcium Channel Blocker"}]},{"@id":"https://cir.nii.ac.jp/crid/1573950400320283776","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Renoprotective Effect of the Addition of Losartan to Ongoing Treatment with an Angiotensin Converting Enzyme Inhibitor in Type-2 Diabetic Patients with Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1574231875581478016","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Oral carbonaceous absorbent modifies renal function of renal ablation model without affecting plasma renin-angiotensin system or protein intake"}]},{"@id":"https://cir.nii.ac.jp/crid/1574231875584275584","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"高血圧と糖尿病"}]},{"@id":"https://cir.nii.ac.jp/crid/2050025942146108160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Compared effects of calcium and sodium polystyrene sulfonate on mineral and bone metabolism and volume overload in pre-dialysis patients with hyperkalemia"}]},{"@id":"https://cir.nii.ac.jp/crid/2050870367073818624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Antihypertensive effect of a fixed-dose combination of losartan /hydrochlorothiazide in patients with uncontrolled hypertension : a multicenter study"}]},{"@id":"https://cir.nii.ac.jp/crid/2051151842051112832","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Nephrotic range proteinuria as a strong risk factor for rapid renal function decline during pre-dialysis phase in type 2 diabetic patients with severely impaired renal function"}]},{"@id":"https://cir.nii.ac.jp/crid/2051996266980601600","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1056/nejmoa011161"},{"@type":"CIA","@value":"30022555104"},{"@type":"CROSSREF","@value":"10.1038/hr.2012.8_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1007/s10157-010-0298-8_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1007/s10157-015-1094-2_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/hr.2012.96_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1152/ajpcell.00017.2011_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1155/2011/506137_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1155/2016/9172157_references_DOI_Foe0soSOIL0wByOhUv5VPPrBNxK"},{"@type":"CROSSREF","@value":"10.1536/ihj.14-429_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.3390/ijms17111800_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.4093/dmj.2015.39.6.451_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.4264/numa.73.8_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1254/jphs.12r03cr_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1007/s00125-019-4948-4_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/j.freeradbiomed.2015.10.414_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/s41440-019-0284-9_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1097/mnh.0000000000000561_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.23876/j.krcp.19.063_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/j.jdiacomp.2018.04.011_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1248/bpb.32.1991_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1253/circj.70.1155_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1291/hypres.26.67_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1292/jvms.70.455_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1536/ihj.53.244_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.44.386_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.48.2627_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.51.7285_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2169/naika.100.191_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2169/naika.100.2592_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1254/jphs.10r08fm_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1291/hypres.25.849_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1291/hypres.25.717_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.3918/jsicm.21.595_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/j.ejphar.2011.04.008_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/j.jdiacomp.2013.03.003_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1248/yakushi.17-00038_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.5551/jat.rv17042_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1007/s13340-020-00471-5_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1093/ndt/gfab336_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/j.cmet.2021.04.004_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1111/jdi.13624_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.34067/kid.0006972020_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1507/endocrj.ej21-0608_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/s41440-022-01061-5_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.3389/fmed.2023.1137981_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1111/nep.14134_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.5551/jat.64798_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2169/naika.112.1680_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/s41440-023-01318-7_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1007/s10157-024-02537-z_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/j.metop.2024.100294_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/s41440-024-02082-y_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/hr.2012.145_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/nrneph.2011.61_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1111/jdi.12624_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1681/asn.2011070734_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1002/sctm.17-0284_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1007/s00204-018-2335-4_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1007/s00380-016-0867-1_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1007/s10157-017-1412-y_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/hr.2010.233_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.14789/pjmj.55.289_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.14789/pjmj.56.100_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1507/endocrj.k06-025_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1536/ihj.48.637_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1272/jnms.82.84_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.51.7408_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.48.1865_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1254/fpj.139.236_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1254/fpj.128.147_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2169/naika.96.904_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.3165/jjpn.25.121_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1291/hypres.26.515_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.3999/jscpt.38.205_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.5649/jjphcs.37.173_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/j.pharmthera.2015.02.001_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1620/tjem.213.203_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1248/yakushi.129.237_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1540/jsmr.53.20_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/s41598-019-46726-3_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1111/jch.14224_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1159/000485593_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1097/hjh.0000000000003099_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/j.kint.2022.01.031_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.23876/j.krcp.21.251_references_DOI_Foe0soSOIL0wByOhUv5VPPrBNxK"},{"@type":"CROSSREF","@value":"10.1093/ndt/gfac242_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.3390/ijms232213749_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1161/jaha.122.029565_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/s41440-024-01683-x_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1159/000530506_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.3390/microorganisms8091347_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/s41581-024-00854-w_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.3390/biomedicines13010053_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1007/s10157-011-0564-4_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1007/s12272-013-0019-4_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/hr.2016.163_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/s41598-018-20874-4_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1093/ndt/gfq371_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1152/ajpheart.00663.2011_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1186/s12882-016-0337-0_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1681/asn.2011121159_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1002/dmrr.3120_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1007/s00592-014-0561-7_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1007/s10557-011-6309-5_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/s41440-017-0008-y_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/s41598-019-41536-z_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/srep27192_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1080/0886022x.2017.1279553_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1080/15569527.2018.1490746_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1093/ndt/gfp520_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1093/ndt/gfs365_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1159/000343244_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1186/1755-1536-4-25_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1186/s40360-015-0024-y_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0086335_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.3389/fphar.2014.00070_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.3390/ijms17111868_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1172/jci.insight.129034_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.3389/fphar.2019.00904_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/j.semnephrol.2013.11.003_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1291/hypres.26.979_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/j.amjcard.2011.01.054_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2957/kanzo.49.339_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.14789/pjmj.51.2_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.7888/juoeh.40.11_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.5551/jat.9084_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.46.1908_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.48.1938_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1254/jphs.12076fp_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1291/hypres.26.123_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.4044/joma.120.215_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.5551/jat.6247_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.4009/jsdt.44.1130_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1291/hypres.25.865_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1291/hypres.26.863_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.5551/jat.2352_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2974/kmj.56.339_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.4044/joma.119.311_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-20-0865_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/j.radonc.2016.04.022_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1056/nejmc1315504_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1111/1744-9987.13616_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1111/nep.13860_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2337/dc21-1081_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1186/s12872-021-02163-7_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/s41581-021-00462-y_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1254/fpj.22008_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1007/s12325-022-02223-0_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.3390/ijms24097719_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1111/1440-1681.13738_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1136/bmjopen-2022-070345_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/s2213-8587(23)00322-4_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/s41581-023-00775-0_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1007/s11906-011-0212-0_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/hr.2011.11_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1155/2013/193757_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1681/asn.2012111080_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1007/s00125-010-2025-0_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1007/s40620-014-0147-z_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/hr.2009.230_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.14789/jmj.2020.66.jmj20-r13_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.46.6415_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2337/dc13-0407_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-08-0140_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1507/endocrj.52.353_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1620/tjem.209.7_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.47.1353_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.44.388_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.45.1515_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1254/fpj.132.166_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1254/jphs.09308fp_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1291/hypres.25.175_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1291/hypres.26.717_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.4091/iken.15.1_17_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1291/hypres.25.271_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1291/hypres.27.379_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1291/hypres.25.683_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-16-0577_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.5264/eiyogakuzashi.69.109_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/s41598-020-73638-4_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1007/s13340-020-00444-8_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1111/jdi.13339_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.4093/dmj.2020.0217_references_DOI_Foe0soSOIL0wByOhUv5VPPrBNxK"},{"@type":"CROSSREF","@value":"10.1080/24709360.2021.1921944_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1136/bmjopen-2021-052246_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1056/nejmoa2204233_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2215/cjn.06870520_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/j.semnephrol.2023.151431_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.14789/ejmj.jmj24-0031-p_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.7143/jhep.52.370_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/s41572-024-00589-9_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/s41440-025-02146-7_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1292/jvms.69.1015_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1097/hjh.0b013e328338bb11_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1248/bpb.34.824_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1038/ki.2012.326_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/j.bbrc.2010.11.139_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.14789/jmj.60.293_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1507/endocrj.51.499_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1291/hypres.26.875_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1097/hjh.0b013e32833dfcda_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/j.ijcard.2011.10.133_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/j.diabres.2011.11.025_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2169/naika.92.suppl_55_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/j.canlet.2014.09.019_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1291/hypres.27.21_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1016/j.jphs.2016.01.003_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2342/ymj.64.17_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.4503-20_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1093/ajh/hpz059_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1097/hjh.0b013e328348ca95_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"},{"@type":"CROSSREF","@value":"10.1254/jphs.09332fp_references_DOI_T14D8RlIDpTXpUjkwxN4HcFVplq"}]}